The effect of physostigmine and neostigmine on the concentration of glycogen in various brain structures of the rat.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001923:Brain Chemistry / Q000187:drug effects*; D002525:Cerebellar Cortex / Q000032:analysis; D002540:Cerebral Cortex / Q000032:analysis; D006003:Glycogen / Q000032:analysis*; D007031:Hypothalamus / Q000032:analysis; D008526:Medulla Oblongata / Q000032:analysis; D008636:Mesencephalon / Q000032:analysis; D009388:Neostigmine / Q000008:administration & dosage* / Q000494:pharmacology*; D010830:Physostigmine / Q000008:administration & dosage* / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats
D009388:Neostigmine; D001285:Atropine; D006003:Glycogen; D010830:Physostigmine; D011433:Propranolol